Skip to main content

Table 2 Outcome scores in mean (range)

From: The results of using a tendon autograft as a new rotator cable for patients with a massive rotator cuff tear: a technical note and comparative outcome analysis

 Preop3 months6 months12 monthsa
Group 1Group 2Group 1Group 2Group 1Group 2Group 1Group 2
CMS pain6.3 (0–10)7.0 (0–15)7.5 (5–10)13.7 (10–15)10.0 (5–10)10.0(5–15)13.3 (10–15)11.0 (0–15)
CMS activity7.0 (4–12)10.4 (4–14)5.0 (4–6)16.5 (15–19)9.3 (4–15)14.8(12–20)16.0 (10–20)16.4 (8–20)
CMS mobility17.5 (10–24)23.6 (8–36)10.0 (8–12)26.0 (20–30)14.5 (8–20)27.2(22–34)20.6 (18–26)30.8 (20–36)
CMS strength12.5 (5–25)9.46 (2–19)12.5 (5–20)9.65 (8–12)14.3 (5–22)10.4(4–18)19.7 (10–25)9.88 (2–17)
CMS total43.3 (31–32)49.0 (26–73)35.0 (28–42)65.9 (61–73)46.5 (28–67)62.0(51–69)69.7 (53–80)68.1 (30–81)
SST5.5 (1–8)4.75 (1–8)5.3 (2–7)6.3 (6–7)
WORC55.3 (36–52)43.3 (39–53)47.7 (32–60)60.3 (49–67)
VAS pain45.0 (30–70)60 (30–80)56.3 (20–80)27 (20–50)37.5 (10–65)38(20–60)16.7 (10–20)26 (10–80)
VAS disability53.3 (8–80)54 (20–10)65.0 (40–85)35 (30–40)46.3 (20–70)42 (30–60)40.0 (15–70)30 (10–80)
VAS satisfaction46.3 (40–50)43.8 (5–60)63.4 (45–85)
  1. Group 1, surgical treatment; group 2, non-surgical treatment
  2. WORC depicted as a percentage of normal/maximum score
  3. aResults of three out of four patients